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Introduction: The different characteristics of the elderly and young people may 
provide different characteristics of COVID-19. This research aim is to provide 
information on the characteristics of COVID-19 patients, especially elderly 
patients. Aim: To analyzed comparisson of clinical characteristics of COVID-19 in 
elderly and young age patients. Method: This study is a retrospective observational 
study with a cross-sectional approach in COVID-19 patients hospitalized at 
Soewandi General Hospital from May 1st 2020, until November 31th 2020. This 
study compared the characteristics of COVID-19 patients at elderly and young 
ages. Result: There were 368 COVID-19 patients with 95 elderly patients (25.81%) 
and 273 young patients (74.19%). The most frequent symptoms experienced by 
elderly patients in sequence are cough, gastrointestinal disturbances, fever, and 
fatigue. It was found that the proportion of COVID-19 patients with comorbid 
diabetes mellitus (DM) and hypertension (HT) was higher in elderly patients than 
in younger patients (p <0.05). There were statistically significant  differences in the 
values of hemoglobin (Hb), lymphocytes, hematocrit, mean platelet volume (MPV), 
neutrophil-lymphocyte ratio (NLR), Serum Glutamic Pyruvic Transaminase 
(SGPT), blood urea nitrogen (BUN), serum creatinine (Sc), and D-Dimer between 
the elderly and young age groups (p <0.05). Conclusion: COVID-19 has different 
clinical and laboratory characteristics between the elderly and young population. 
In the elderly infected with the COVID-19 population, we need more comprehensive 
clinical and laboratory evaluation to prevent COVID-19 morbidity and mortality.  
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ABSTRAK 
Latar belakang: Perbedaan karakteristik pada lanjut usia (lansia) dan usia muda 
mungkin dapat memberikan gambaran karakteristik COVID-19 yang berbeda. 
Melalui penelitian ini diharapkan dapat memberikan informasi karakteristik pasien 
COVID-19, terutama pada pasien lansia. Tujuan: Menganalisis perbedaan 
karakteristik klinis dari COVID-19 pada pasien lansia dan usia muda. Metode: 
Penelitian ini merupakan studi observasional retrospektif dengan pendekatan belah 
lintang pada pasien COVID-19 yang dirawat inap di Rumah Sakit Umum Soewandi 
pada periode 1 Mei 2020 hingga 31 November 2020. Penelitian ini membandingkan 
karakteristik pasien COVID-19 pada lansia dan usia muda. Hasil: Total  pasien 
COVID-19 diperoleh 368 orang, yang terdiri dari 95 pasien lansia (25,81%) dan 
273 pasien usia muda (74,19%). Gejala paling sering yang dialami pasien lansia 
adalah batuk, gangguan gastrointestinal, demam, dan lemas. Proporsi pasien 
COVID-19 dengan komorbid diabetes melitus (DM) dan hipertensi (HT) lebih 
banyak pada pasien lansia dibandingkan pasien usia muda (p <0,05). Terdapat 
perbedaan bermakna secara statistik pada nilai hemoglobin (Hb), limfosit, 
hematokrit, mean platelet volume (MPV), rasio neutrofil limfosit (NLR), Serum 
Glutamic Pyruvic Transaminase (SGPT), blood urea nitrogen (BUN), serum 
creatinine (Sc), dan D-Dimer antara kelompok lansia dan usia muda (p <0,05). 
Kesimpulan: COVID-19 memiliki karakteristik klinis dan laboratorium yang 
berbeda antara populasi lansia dan usia muda. Populasi lansia yang terinfeksi 
COVID-19 memerlukan evaluasi klinis dan laboratorium yang lebih komprehensif 
untuk mencegah morbiditas dan mortalitas karena COVID-19.  
Kata Kunci: COVID-19, Pasien Lansia, Parameter Hematologis. 
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Coronavirus Disease 2019 
(COVID-19) by the World Health 
Organization (WHO) has caused 
disasters and burdens in all countries, 
including Indonesia1. Data in 
Indonesia until February 10th 2021, 
most people with COVID-19 were 
aged 31-45 years (29.86%), patients 
aged 19-30 years (24.95%), patients 
aged 46-59 years (22.64%), sufferers 
aged ≥ 60 years (10.66%) and patients 
aged ≤ 18 years (11.89%). The elderly 
group had the highest mortality rate 
(47.8%) 2. Those data has shown that 
the age factor plays a role in the 
severity of COVID-19 and caused 
mortality. 
Clinical findings patients with 
COVID-19 are varied widely, from 
asymptomatic to acute respiratory 
distress syndrome 3. Elderly patients 
have varied symptoms; several 
studies have shown that cough, fever, 
shortness of breath, and fatigue are 
the most common symptoms 4,5,6. The 
majority of elderly patients were aged 
60-69 years, male, and had no history 
of contact with COVID-19 patients 
before 6. Elderly patients also had a 
higher Pneumonia Severity Index 
score 5. 
Most of the elderly had 
underlying diseases, and the most 
common are cardiac disease, 
hypertension, diabetes mellitus, and 
cerebrovascular disease 4,5. In 
Indonesia, the majority of patients 
with covid-19 had comorbidities, 
such as hypertension (50.7%), 
diabetes mellitus (34.8%), and 
cardiac disease (17.7%) 2. This data 
had shown that the elderly with 
comorbidities have significant 
correlations with the risk of infection 
in COVID-19. However, some 
studies state that there are no 
correlations between comorbid with 
the severity of covid-19 6. 
Laboratory findings are 
needed for patients with covid-19, 
such as coagulant factor and 
fibrinolysis factor (LED, CRP, 
ferritin, and pro-calcitonin) 7. 
laboratory findings in elderly patients 
were different compared to the young 
population. An elderly patient had 
higher CRP and D-dimer4. 
Lymphocytes slightly lower in elderly 
patients 5. Blood urea nitrogen (BUN) 
and serum creatinine were also higher 
in elderly patients. Those renal 
function results may be associated 
with decreased kidney function 
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because of the aging process 4. 
Elderly patients may be at risk of 
suffering more severe symptoms of 
Covid-19 because of multiple 
comorbid factors and the body's 
immune system that is no longer 
optimal due to age. This research aims 
were to compare the different 
characteristics of COVID-19 patients 
between the elderly population (age ≥ 
60 years) and the young population 
(aged 18-60 years). 
 
METHODS 
This study is a retrospective 
observational study with a cross-
sectional approach that examined 
COVID-19 patients hospitalized at 
Soewandhi General Hospital from 
May 1st 2020 until November 31th 
2020. Diagnosis of COVID-19 was 
based on positive PCR swab results. 
This study divides the research 
sample into two research groups. The 
first group is elderly patients (age> = 
60 years), and the second group is 
young patients (aged 18-59 years). 
Identity data, clinical symptoms, 
comorbid and laboratory data were 
obtained from medical records. 
The COVID-19 severity is 
based on the guidelines for managing 
COVID-19. The criteria of mild 
degrees are patients without evidence 
of pneumonia or hypoxia (saturation 
95%). The moderate degree is a 
patient with clinical signs of 
pneumonia (fever, cough, shortness 
of breath, rapid breathing) but no 
signs of severe pneumonia, including 
SpO293%. The severe degree is a 
patient with clinical signs of 
pneumonia (fever, cough, shortness 
of breath, rapid breathing) plus one of 
the following symptoms: respiratory 
rate> 30x / minute, severe respiratory 
distress, or SpO2 <93%.8 
Parametric variables were 
described as medians and quartile 
ranges (Q1-Q3). Non-parametric 
variables were described by numbers 
(percentages). The independent t-test 
was used if the parametric data  were 
normally distributed, and the Mann-
Whitney U test was used if the 
parametric data were not normally 
distributed. The Chi-square test was 
used to analyze non-parametric 
variables of 2x2 tables. The statistical 
test used SPSS version 23.0, and the 
p-value <0.05 had a statistically 
significant value.  
 
 
Clinical Characteristic Of....  Wulandari Y, Supit VD, Asaleo H, Marentek  




In this study, 368 patients with 
confirmed COVID-19 were found. 
There were 95 elderly patients 
(25.81%) and 273 young patients 
(74.19%). There was no statistically 
significant gender difference (p = 
0.868) between the elderly and 
middle-aged adult groups, with more 
female patients than male patients. 
There were differences in systole, 
diastole, pulse, and O2 saturation 
which were statistically significant (p 
= 0.015; p = 0.006; p = 0.028; p = 
0.041) between the elderly and young 
groups. There was higher systole in 
the elderly patient's group compared 
with the middle-aged adult group. 
Diastole, heart rate, and O2 saturation 
were lower in the elderly group than 
in middle-age adults. There was no 
statistically significant difference in 
respiratory rate, temperature, and 
length of stay (p = 0.278; p = 0.691; p 
= p = 0.38) between the elderly and 
young groups.(Table 1) 
 
Table 1. Clinical Characteristic Comparison Between COVID-19 Elderly Patients 
and Middle-Age Adult Patients  
Clinical Characteristic 
Elderly (n = 95) 
Middle-age Adult (n = 
273) P-Value 
Median Q1-Q3 Median Q1-Q3 
Gender 
Male 46 (47.9%) 134 (48.9%) 
0.868 
Female 50 (52.1%) 140 (51.1%) 
Age (years) 65 62 – 71 48 38.5 – 54 0.000** 
Systole (Mm Hg) 140 124 – 159 130 118 – 147 0.015* 
Diastole (Mm Hg) 78 68 – 9 81 73 – 90 0.006* 
Heart rate 
(beats/minute) 
92 81 – 105 98 85.5 – 110 0.028* 
Respiration rate 
(/minute) 
20 20 – 24 20 20 – 24 0.278 




O2 Saturation (%) 96 92 - 98 98 94 – 98 0.041** 
Length of stays (days) 11 7-15 10 6 - 15 0.380 
*T-independent test statistical significant (p < 0.05) 
**Mann-Whitney U test statistical significant (p < 0.05) 
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In this study, there were 
differences in the number of COVID-
19 patients with comorbid diabetes 
mellitus (DM) and patients with 
comorbid hypertension (HT), which 
were statistically significant between 
the elderly and young groups (p = 
0.003; p = 0.004). It was found that 
COVID-19 with comorbid DM in the 
elderly group (n = 47; 49.5%) was 
higher in the middle-aged adult 
group. It was found that there were 
more COVID-19 patients with 
comorbid HT (n = 45; 47.4%) in the 
elderly group than in the middle-aged 
adults group. It was found that clinical 
symptoms of fatigue were more 
common in the elderly group (n = 36; 
37.9%) compared to the middle-aged 
adult group with a significant 
statistical test (p = 0.008). The clinical 
symptom of cough was the most 
common clinical symptom in both the 
elderly group (56.8%) and  middle-
aged adults (65.9%). There were no 
statistically significant differences in 
the clinical symptoms of fever, cough, 
headache, fatigue, and 
gastrointestinal disorders between the 
elderly and middle-aged adult groups 
(p> 0.05). There was no statistically 
significant difference in the severity 
of COVID-19 (p = 5.25), but in the 
elderly group, the number of patients 
experiencing severe degrees was 
higher than the middle-aged adult 
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Table 2. Comorbidity and Clinical Characteristic of COVID-19 Patients Between 
Elderly and Middle-Age Adult. 





(Age 18-60 years) 
Diabetes mellitus (DM) 
No 48 (50.5%) 184 (67.4%) 
0.003* 
Yes 47 (49.5%) 89 (32.6%) 
Hypertension (HT) 
No 50 (52.6%) 188 (68.9%) 
0.004* 
Yes 45 (47.4%) 85 (31.1%) 
Fever 
No 58 (61.1%) 166 (60.8%) 
0.966 
Yes 37 (38.9%) 107 (39.2%) 
Cough 
No 41 (43.2%) 93 (34.1%) 
0.113 
Yes 54 (56.8%) 180 (65.9%) 
Fatigue 
No 59 (62.1%) 208 (76.2%) 
0.008* 
Yes 36 (37.9%) 65 (23.8%) 
Headache 
No 84 (88.4%) 246 (90.1% ) 
0.641 
Yes 11 (11.6%) 27 (9.9%) 
Dyspnea 
No 45 (47.4%) 126 (46.2%) 
0.838 
Yes 50 (52.6%) 147 (53.8%) 
 Gastrointestinal disturbance 
No 56 (58.9%) 178 (65.2%) 
0.275 
Yes 39 (41.1%) 95 (34.8%) 
Severity 
Mild 58 (61.1%) 172 (63%) 
0.525 Moderate 14 (14.7%) 51 (18.7%) 
Severe 23 (24.2%) 50 (18.3%) 
*Chi-Square test statistical significant (p < 0.05)
In this study, there were 
statistically significant differences in 
the values of hemoglobin (Hb), 
lymphocytes, hematocrit, mean 
platelet volume (MPV), neutrophil-
lymphocyte ratio (NLR), SGPT, 
blood urea nitrogen (BUN), serum 
creatinine (Sc), and D-Dimer between 
elderly and middle-aged adult groups 
(p <0.05). It was found that the Hb, 
lymphocyte, hematocrit, MPV, and 
SGPT values were lower in the 
elderly group than in the middle-aged 
adults group. It was found that the 
NLR, BUN, Sc, and D-dimer values 
were higher in the elderly group than 
in the middle-aged adult group. There 
were no statistically significant 
differences in the values of 
leucocytes, neutrophils, monocytes, 
platelets, absolute lymphocyte count 
(ALC), SGOT, sodium, and 
potassium (p> 0.05). (Table 3)
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Table 3. Laboratory Comparison Results  
* Mann-Whitney U test test statistical significant (p < 0.05)
DISCUSSION 
The difference in the total case 
of infectious disease often is linked 
with three factors: the difference in X 
chromosome-related immune 
function, sexual hormones influence, 
and the difference in gender-related 
behavior9. In this research, no 
significant (p = 0.868) gender 
difference was seen in  young and 
elderly groups, with more females 
than male patients. 
In this research, there were 
more young patients than elderly 
patients. Findings in this research  
were in line with the findings from 
previous one, which there were more 
patients with middle-age adults 
infected with COVID-19 10. This 




Middle-age adult  
(Age 18-60 years) P-Value 
Median Q1 -Q3 Median Q1 - Q3 
Hemoglobin (Hb) 13.1 11.675 - 14 13.6 12.2 – 14.975 0.007* 
Leukocyte (103/µl ) 9.15 6.812 – 12.922 7.9 5.85 – 11.042 0.023 
Neutrophil (%) 73.5 65.575 – 84.25 70.55 63.5 – 79.25 0.055 
Lymphocyte (%) 15.95 9.475 – 22.875 19.75 13.225 – 26.175 0.008* 
Monocyte (%) 7.5 5.55 – 10.085 7.1 5.7 – 9.05 0.333 
Hematocrit (%) 38.25 34.575 – 40.95 40.1 36.1 – 43.05 0.002* 
Thrombocyte (103/µl) 298.5 213 - 410 287 218.5 - 357 0.464 
Mean platelet volume 
(MPV) (fL) 
9.5 9.1 – 10.125 9.8 9.225 – 10.6 0.018* 
NLR (Neutrophil 
lymphocyte ratio) 
4.421 2.8598 – 8.8294 3.5189 2.425 – 5.871 0.009* 
ALC (Absolute 
lymphocyte count) 













33 24 – 50.5 45 29.25 – 72.75 0.006* 
Blood urea nitrogen 
(BUN)(mg/dL) 
17 12.75 – 22.5 11 9 - 17 0.000* 
Serum creatinin (Sc) 1.2 1.4 – 1.7 0.9 0.8 – 1.2 0.000* 
Sodium (mmol/L) 139 135 - 143 141 138 - 144 0.094 
Potassium (mmol/L) 4.1 3.6 4.1 3.8 0.785 
D-Dimer(µg/L) 640.5 390.8 444.5 252.9 0.003* 
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middle-aged adult population who 
tend to have more SARS-CoV-2 virus 
exposure because of their busy daily 
activity compared to the elderly. 
Many factors contribute to 
morbidity and mortality in patients 
with COVID-19; there are  age, 
diabetes mellitus (DM), and 
hypertension 11. In this study, the 
elderly with COVID-19 infection had 
DM comorbid higher prevalence than 
a middle-aged adult with COVID–19. 
The elderly population had diabetes 
mellitus prevalence higher than the 
middle-aged adult population. DM 
can increase viral affinity in the cell, 
which will make the virus get in 
quickly into our body. Diabetes 
mellitus also reduces T-cell function, 
contributing to a defense mechanism 
against the virus, increasing the risk 
of hyper inflammation state, and 
cytokine storm syndrome12. Some 
studies described increasing 
Angiotensin-converting enzyme 2 
(ACE2) expression in lung which had 
a role in the entry of the virus in DM 
patients13. These reasons might 
explain that patients with DM have a 
higher probability of COVID–19 
infection than patients without DM 
comorbid. 
The study from Zhang et al. 
describes the elderly population with 
DM and COVID–19 had a risk of 
severe symptoms and decreased O2 
saturation compared with the elderly 
population without DM. Elderly 
patients with DM have inferior 
laboratory markers (albumin, blood 
urea nitrogen, lactate dehydrogenase  
C-Reactive Protein, and D-dimer)  
than elderly patients without DM14. 
SHAP’s Study analysis showed 
patients with high blood glucose-
related with a bad prognosis on 
COVID–19 infection in elderly 
population 15.  
Hypertension is one of the 
most common comorbidities in the 
elderly population16. With increasing 
age, there is a change in body 
function, for example arterial 
stiffness, neurohormonal and 
autonomic dysregulation, decreased 
immune system and decreased kidney 
function.17 In Elderly using 
antihypertensive drug is much more 
common compared to middle-age 
population and at an older age there is 
reduced arterial compliance, this 
might explain lower diastolic blood 
pressure in elderly.18 These changes 
might contribute to hypertension and 
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explain why the geriatric population 
had hypertension comorbidities more 
than the middle-aged adult 
population.  
Some studies found that 
hypertension is a comorbid factor in 
COVID–19 patients with severe 
symptoms 19. The study from Italy 
concludes that a higher prevalence of 
COVID-19 infection was at risk in 
hypertension patients 20. In 
conclusion, these three problems are 
related to COVID-19 infection. 
Starting from elderly patients with 
hypertension, age factor, and 
hypertension are also related to 
COVID–19 severity. 
Clinical symptoms in patients 
with Covid 19 vary between age 
groups. Diarrhea is most often seen in 
patients aged 1-19; fever often occurs 
in patients aged 20-49; meanwhile, 
cough is more often observed in 
patients aged 40-79. 21 Other studies 
regarding COVID-19 in elderly 
patients found that fever and cough 
are the dominant symptoms, followed 
by fatigue and dyspnea. Other 
symptoms that are less often seen are 
diarrhea, anorexia, headache, 
myalgia, and vomiting. 22 In this 
study, the clinical symptom fatigue is  
often found in the elderly group (n = 
36; 37.9%) than the middle-aged 
adult group with statistical 
significance difference (p = 0.008). 
There is a statistically significant 
difference in fever, cough, headache, 
dyspnea, and gastrointestinal 
symptoms between age groups (p > 
0,05). 
The elderly are associated 
with more severe symptoms of 
COVID-19 than the younger 
population. This phenomenon is 
associated with deterioration of 
immune function in the elderly 
(immunosenescent), continual 
production of inflammatory 
mediators and cytokines, functional 
decline of upper respiratory tract 
clearance, and  comorbidities in the 
elderly.23 In this study, the prevalence 
of COVID-19 patients with severe 
symptoms is higher in the elderly 
population (24.2%) than in the 
younger population (18.3%), 
although there is no significant 
association between old age and the 
severity of the symptoms. This study 
is similar to what Wei et al. found, 
that the older patients were more 
likely to present more severe 
symptoms, exhibit significant 
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systemic inflammation, pulmonary 
and extrapulmonary organ damage, 
and a higher mortality.22. 
In complete blood count, we 
found  significant differences in 
hemoglobin, leucocyte, and 
hematocrit in the elderly than in 
younger patients, while the 
thrombocyte count did not differ in 
elderly and younger patients. 
Although we found a significant 
difference, hemoglobin, leucocyte, 
and hematocrit counts between the 
two groups were still within normal 
limit. Low hemoglobin count in 
COVID-19 patients might be 
associated with systemic 
inflammation, which disrupts the 
erythropoiesis process. Excessive 
production of IL-6 affects iron 
metabolism, while other pro-
inflammatory cytokines (interferon-γ, 
IL-1, IL-33, and TNF-α) inhibit 
progenitor and precursor cells and 
may reduce erythrocyte lifespan 24. 
Lower hemoglobin counts in the 
elderly compared to younger patients 
might be caused by malnutrition and 
decreased effective erythropoiesis 
function.25 Similar observation has 
been reported by Wei et al., and Zhao 
et al., Wei et al., who found lower 
hemoglobin in elderly patients, and 
Zhao et al. found that the older 
patients with COVID-19 had 
underlying chronic disorders are more 
likely to develop leucocytosis. 25,26. 
Patients with COVID-19 had 
a lower lymphocyte count and more 
severe lymphopenia occurred in 
elderly patients. This phenomenon 
might be related to immunosenescent 
which is an age-related process that 
affects both adaptive and innate 
immunity, therefore elderly are more 
susceptible to infectious disease. 
Immune organs, such as thymus and 
lymph node atrophy, gradually with 
age and profoundly affect the 
phenotype and function of various 
immune cells.25 In this study, the 
elderly had significantly lower 
lymphocyte count (15.95%) than in 
younger patients (19.75%). 
Conversely, the neutrophil count is 
higher in the elderly than in younger 
patients, although this difference is 
statistically insignificant. The higher 
count of neutrophils in the elderly 
suggests an augmented inflammatory 
response, especially in the elderly 
with comorbidities.25,26 Our 
observation is similar to Wei et al., 
who found a decrease of lymphocytes 
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and increased neutrophil count.25 The 
study from S.-P Dai et al. showed 
significant decreased number of 
CD8+ T lymphocytes and B 
lymphocytes in elderly patients that 
suggesting indicate low immune 
function in elderly compared with 
middle-age group.27 
 Our study showed significant 
results between MPV value in eldery 
and younger patients with COVID-
19. There was a similar result in Hu 
Yun et al. and Zong et al.'s The 
increase of  MPV value may occur 
because of systemic inflammation 
and hypercoagulation. Because of 
that, production of thrombopoietin 
and megakaryocyte increased by 
medulla spinalis.28,29 In our study, 
MPV values were higher in younger 
patients than in elder patients. This 
study results were also in line with 
Fabio Perotta et al. study that found 
MPV in younger patients was much 
higher than in elderly patients  
because of the immunosenescence 
process.30 In another study, there were 
no significant differences in platelet 
and MPV value among elderly and 
younger patients.31 Different results 
were found by Pinti et al. that MPV 
value is much higher in elderly than 
younger patients. The cause of higher 
MPV values in elderly patients is  the 
upregulation of TLR4, which can 
result in uncontrolled systemic 
immune response and platelet 
activation32. 
 Our study showed a high 
NLR value in an elderly and younger 
patient with COVID-19. The result 
was in line with Liu et al. study33. The 
cause of higher NLR is because an 
increase of total leucocyte count and  
destroyed lung cells trigger innate 
immune response mediated by 
macrophage and granulocyte.33 In our 
study, there was a higher increase in 
NLR value in elderly than younger 
patients. Our results were also similar 
to Liu et al. study. In that study, 
patients over 50 years have higher 
NLR value and higher mortality.33 
The older the patient, the NLR value 
and severity of the patient will 
increase.34  
In our study, there was no 
significant correlation between ALC 
values between elderly and younger 
patients. Our result differs from 
Huang et al., that found ALC has a 
significant correlation in elderly than 
younger patients. ALC value was 
much higher in the younger patient 
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than the elderly. This may be because 
of the aging process in the immune 
system of the elderly that causes a 
decrease in the production of 
lymphocyte.35 
 There were significant 
differences in liver function tests 
results, where the SGPT results were 
significant between the elderly group 
(median = 33) and the middle-aged 
adult group (median = 45). However, 
in contrast to SGOT value, the results 
were not significant between the two 
groups. In a study conducted in 
Wuhan comprising 339 elderly 
COVID-19 patients; There was no 
significant difference in SGPT results 
between elderly COVID-19 patients 
who died and elderly COVID-19 
patients who survived.36 The experts 
think that abnormal liver function 
tests are common in patients with 
COVID-19, but clinically significant 
liver function impairment may not be 
a prominent symptom of COVID-
19.37  
Besides liver function tests, 
there were also significant results for 
kidney function tests. The difference 
in BUN and SCr values was 
significant between elderly and young 
patients (p = 0.000). Where in elderly 
groups, the BUN and SCr values are 
higher than the young patients. 
Another study in Wuhan found 
significantly higher BUN and Scr 
values in COVID-19 elderly patients 
who died. 37 Recent studies have 
shown that SARS-CoV-2 can directly 
affect kidney cells, so this can result 
in high BUN levels can predict 
mortality in the elderly with COVID-
19.38,39  
In our study, elderly patients 
had a higher D-dimer; they had D-
dimer level 640.5 than middle-aged 
adults at 440,5 (p<0,05). Some 
studies also had the same result as 
ours; Guo, et al. and Yuan X et al. 
state that d-dimer level increased in 
elderly patients 4,40. In Guo, et al. 
study, the elderly had a higher level of 
D-dimer, but no subjects were 
diagnosed with VTE (Venous 
Thrombo Embolism). This suggests 
that the elevated D-dimer is 
associated with COVID-19 infection 
4. Severe COVID-19 can cause 
cytokine storm and systemic 
inflammation, leading to 
hypercoagulation, which could 
elevate D-dimer value 41. These 
events explained that elevated D-
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dimer might evaluate prognosis and 
patient severity 4,40. 
 Based on the discussion 
above, this study found  some 
different characteristics between elder 
patients and young patients infected 
with COVID-19 infection. Elderly 
patients infected with COVID-19 
might need a more comprehensive 
examination and approach because of 
multiple comorbidities. Further study 
might need to evaluate other factors 
that differ from elder patients and 
young patients infected with COVID-
19 infection. 
LIMITATION 
 There was some limitations in 
this study. This study is not dynamic 
in following the patient's condition 
every day. The relatively small 
number of samples in the elderly 
category may influence the results of 
the study. Thus, further research is 
needed to overcome this limitation.  
CONCLUSION 
 COVID-19 has different 
clinical and laboratory characteristics 
between the elderly and young 
population. Severe severity and 
various comorbidities are more often 
found in the elderly population than 
middle-aged adults, and this makes us 
need to be more vigilant in dealing 
with elderly patients infected with 
COVID-19. Elderly patients also 
experience an increase in D-dimer 
more often than middle-aged adults, 
making it necessary to do D-dimer 
examination, especially in elderly 
patients. Through the COVID-19 
vaccination program in the elderly 
population, it is hoped that it can 
reduce the morbidity and mortality 
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